Zai Lab Limited (ZAILF)
argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy
Elevai Labs (ELAB)
Northstrive Biosciences Announces Completion of Phase II of AI Development Program with YuvaBio Using MitoNova™ Artificial Intelligence (AI) Platform to Develop Therapies for Obesity and Cardiometabolic Diseases
Repligen Corporation (RGEN)
ZEN Graphene Solutions Ltd (ZTEK)
Pacira BioSciences Inc (PCRX)
ICON plc (ICLR)
Progyny Inc (PGNY)
Elevai Labs (ELAB)
New Form 8-K - PMGC Holdings Inc. Filed: 2025-09-04 AccNo: 0001213900-25-084303 Size: 4 MB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Immunoprecise Antibodies Ltd (IPA)
IPA (ImmunoPrecise Antibodies) rebrands as MindWalk
Aethlon Medical Inc (AEMD)
Aethlon Medical Announces Pricing of $4.5 Million Public Offering
TNF Pharmaceuticals, Inc. (TNFA)
TNF Pharmaceuticals Announces Closing of $7 Million Private Placement
Alvotech (ALVOW)
Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York
Alvotech (ALVO)
Alvotech tekur þátt í 23. árlegu heilbrigðisráðstefnu fjárfestingabankans Morgan Stanley í New York
Alvotech (ALVO)
Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York
Avita Medical, Inc. (AVHHL)
Aethlon Medical Announces Pricing of $4.5 Million Public Offering